18.7 C
New York
Saturday, June 3, 2023

Investing In Becton Dickinson and Company (NYSE: BDX): Why Should You?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Becton Dickinson and Company (BDX) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$5.28, or -2.00%, to $258.51. The Becton Dickinson and Company has recorded 61,954 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed BD to Present at Bank of America Securities 2023 Health Care Conference.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

The company is listed on the NYSE and operates within the Medical Instruments & Supplies industry segment. At the end of the last regular session, the stock closed at $263.79 and fluctuated between $265.00 as its day high and $262.43 as its day low. The current market capitalization of Becton Dickinson and Company is $74.47B. A total of 1.2 million shares were traded on the day, compared to an average of 1.08M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, BDX has seen 1 BUY and 6 SELL insider trades, representing the acquisition of 8,229 and the disposition of 3,448 shares. Over the last 12 months, there were 39 BUYs and 30 SELLs from insiders. Insiders purchased 134,246 shares during that period but sold 68,589.

In the most recent transaction, Byrd Richard sold 1,421 shares of BDX for 248.60 per share on Feb 03. After the transaction, the EVP & President Interventional now owns 4,119 company shares. In a previous transaction on Aug 15, Polen Thomas E Jr sold 9,500 shares at 265.13 per share. BDX shares that Chairman, CEO and President owns now total 28,878.

Among the insiders who sold shares, Hickey David disposed of 475 shares on Aug 15 at a per-share price of $265.00. This resulted in the EVP & President, Life Sciences holding 3,331 shares of BDX after the transaction. In another insider transaction, Khichi Samrat S. sold 9,185 shares at $260.44 per share on Aug 09. Company shares held by the EVP and General Counsel now total 5,928.


The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Becton Dickinson and Company pays an annual dividend of $3.64, resulting in a dividend yield of 1.38%, and it has a price to earnings (P/E) ratio of 50.96. BDX’s most recent ex-dividend date was 6/8/2023 when it declared a $0.91 quarterly dividend that was paid in cash on 6/30/2023. Previously, the company paid the dividend on 3/31/2023 with an ex-dividend date of 3/9/2023. The BDX stock dividend was $0.91 per share in cash.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for BDX in the last 3 months, the mean price target is $276.33 with high estimates of $304.00 and low estimates of $245.00. In terms of 52-week highs and lows, BDX has a high of $269.06 and a low of $215.90.

As of this writing, BDX has an earnings estimate of $2.74 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of $2.78 per share and a lower estimate of $2.7. The company reported an EPS of $2.75 in the last quarter, which was 0.40% higher than expectations of $2.74.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BDX’s latest balance sheet shows that the firm has $2.29B in Cash & Short Term Investments as of fiscal 2021. There were $17.61B in debt and $6.63B in liabilities at the time. Its Book Value Per Share was $89.72, while its Total Shareholder’s Equity was $23.68B.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 17 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BDX is Underweight with a score of 4.21. A total of 10 analysts rated the stock as Buy while 1 rated it as Overweight while 6 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles